JUN 09, 2015 12:30 PM PDT

Own the Histology Process

Speakers
  • Technical Application Manager, Leica Biosystems
    Biography
      Andrew Lisowski M.S., HTL (ASCP) is currently the Technical Application Manager at Leica Biosystems, Richmond, Illinois. Andrew has a Master's degree in Molecular Biology from the Northeastern Illinois University, Chicago, Illinois. His current role with Leica Biosystems involves histology training and technical training for consumables in histology. He also works on the R&D team for quality and supports of the new product development. Andrew is an author of different publications including, ‘Gene expression analysis in rats treated with experimental acetyl-CoA carboxylase inhibitors suggests interactions with the PPAR alpha pathway', Journal of Pharmacology and Experimental Therapeutics, 2007.

    Abstract:
    Histology laboratories are complex with multiple steps for quality, efficiency, patient care and workflow. This presentation is to give ideas on how to improve quality in the histology laboratories, how consumables might impact the efficiency in the laboratories, and a discussion on how to possibly deliver a higher confidence in the histology laboratories for patient care. Learning Objectives: Ideas on improving quality through histology will be discuss. An overview of how consumables in the histology laboratory might impact efficiency in the laboratory. A discussion of how to deliver a higher confidence in the histology laboratory for possible patient care will be reviewed.

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    OCT 19, 2017 08:00 AM PDT
    C.E. CREDITS
    OCT 19, 2017 08:00 AM PDT
    DATE: October 19, 2017TIME: 08:00am PDT, 11:00am EDT Recent FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients more promise than...
    Loading Comments...